Arkolith/Insider Trading/EKSO/Form 4

Sherman Steven

CEO & Chairman, DirectorEKSO BIONICS HOLDINGS, INC. (EKSO) · full profile →Form 4 · filed Nov 23, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$7K
Net Open-Market Flow
-$7K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 21, 2022Option exercise(M)16K—$0714K
Nov 21, 2022Sell(S)6K$1.26$7K708K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 21, 2022Option exercise(M)16K—$031K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001549084-22-000073) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML